002162 悦心健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.6460.816-16.1775.009-24.320
总资产报酬率 ROA (%)0.2730.337-6.6622.057-10.644
投入资产回报率 ROIC (%)0.3160.398-8.0092.462-12.571

边际利润分析
销售毛利率 (%)25.35923.37521.32522.44321.590
营业利润率 (%)1.9360.736-9.1463.297-25.118
息税前利润/营业总收入 (%)3.3222.550-7.6114.816-23.517
净利润/营业总收入 (%)1.4120.563-12.4593.758-24.106

收益指标分析
经营活动净收益/利润总额(%)143.50284.39022.495-24.29514.337
价值变动净收益/利润总额(%)19.14068.5905.242409.9773.279
营业外收支净额/利润总额(%)-16.27214.2521.154-6.9022.928

偿债能力分析
流动比率 (X)1.0060.9020.8571.0500.988
速动比率 (X)0.8050.6820.6460.8190.739
资产负债率 (%)56.85656.79158.99957.03159.437
带息债务/全部投入资本 (%)41.43339.92042.13739.73541.222
股东权益/带息债务 (%)117.226123.802114.307127.566115.799
股东权益/负债合计 (%)73.87274.69368.07273.77467.516
利息保障倍数 (X)2.0051.507-4.6332.781-9.971

营运能力分析
应收账款周转天数 (天)37.92142.95054.84967.20686.582
存货周转天数 (天)65.54466.75867.48978.589110.134